Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis

INTRODUCTION: Cholangiocarcinoma (CCA) is an aggressive disease with limited effective treatment options. The PI3K/Akt/mTOR pathway represents an attractive therapeutic target due to its frequent dysregulation in CCA. MK2206, an allosteric Akt inhibitor, has been shown to reduce cellular proliferati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Wilson, Jacob M, Kunnimalaiyaan, Selvi, Kunnimalaiyaan, Muthusamy, Gamblin, T Clark
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324843/
https://ncbi.nlm.nih.gov/pubmed/25674039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-015-0161-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados